Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer

The anaplastic lymphoma kinase (ALK) is recognized by the immune system as a tumor antigen, and preclinical evidence suggests that ALK-rearranged NSCLCs can also be successfully targeted immunologically using vaccine-based approaches. In contrast to ALK-rearranged lymphomas, the frequency and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Mark M., Mastini, Cristina, Blasco, Rafael B., Mologni, Luca, Voena, Claudia, Mussolin, Lara, Mach, Stacy L., Adeni, Anika E., Lydon, Christine A., Sholl, Lynette M., Jänne, Pasi A., Chiarle, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696179/
https://www.ncbi.nlm.nih.gov/pubmed/29190913
http://dx.doi.org/10.18632/oncotarget.21182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696179/
https://www.ncbi.nlm.nih.gov/pubmed/29190913
http://dx.doi.org/10.18632/oncotarget.21182

Ejemplares similares